Catalyze: Product Definition for Small Molecules, Biologics and Combination Products - Target Identification and Validation, and Preliminary Product/Lead Series Identification (R61/R33 Clinical Trials Not Allowed)
Agency: National Institutes of Health
Assistance Listings: 93.838 -- Lung Diseases Research
93.839 -- Blood Diseases and Resources Research
93.837 -- Cardiovascular Diseases Research
93.233 -- National Center on Sleep Disorders Research
Description
Eligibility
Eligible applicants
Government
- County governments
- City or township governments
- Public and Indian housing authorities
- Special district governments
- State governments
- Federally recognized Native American tribal governments
Nonprofit
- Other Native American tribal organizations
- Nonprofits non-higher education without 501(c)(3)
- Nonprofits non-higher education with 501(c)(3)
Miscellaneous
- Other
Education
- Independent school districts
- Public and state institutions of higher education
- Private institutions of higher education
Business
- For-profit organizations other than small businesses
- Small businesses
Additional information
Grantor contact information
Description
See Section VII. Agency Contacts within the full opportunity announcement for all other inquires.
Documents
| File name | Description | Last updated |
|---|---|---|
| RFA-HL-26-017-Full-Announcement.html | RFA-HL-26-017 Full Announcement Text | Nov 22, 2024 04:18 PM UTC |
Link to additional information
https://grants.nih.gov/grants/guide/rfa-files/RFA-HL-26-017.html
Closing: December 23, 2027
Award
$--
Program Funding
--
Expected awards
$--
Award Minimum
$--
Award Maximum
Funding opportunity number:
RFA-HL-26-017
Cost sharing or matching requirement:
Funding instrument type:
Grant
Opportunity Category:
Discretionary
Opportunity Category Explanation:
Category of Funding Activity:
Health
Category Explanation:
History
Version:
1
Posted date:
November 22, 2024
Archive date:
January 28, 2028
